1.
Int J Dermatol
; 39(9): 719-20, 2000 Sep.
Article
in English
| MEDLINE
| ID: mdl-11044202
2.
Horm Metab Res Suppl
; 22: 42-6, 1990.
Article
in English
| MEDLINE
| ID: mdl-1975246
ABSTRACT
Long-term glycaemic control measured by glycosylated haemoglobin concentration was compared in hypertensive NIDD's taking placebo, alpha-blockers, beta-blockers (alone and in combination) and an ACE inhibitor (enalapril) each for 4 months. Alpha-blockade caused no deterioration in long-term glycaemic control in NIDD's. Beta-blockers caused a deterioration in glycaemic control in NIDD's (with some adverse effects on lipid profile). This was especially apparent with the lipophilic beta-blocker P. Concurrent use of an alpha-blocker with a beta-blocker prevents the deterioration due to beta-blockade. The ACE inhibitor, enalapril caused an improvement in long-term glycaemic control without alteration of lipid control in NIDD's.
Subject(s)
Adrenergic alpha-Antagonists/adverse effects , Adrenergic beta-Antagonists/adverse effects , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/complications , Hypertension/complications , Lipids/blood , Adrenergic alpha-Antagonists/therapeutic use , Adrenergic beta-Antagonists/therapeutic use , Adult , Aged , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Diabetes Mellitus, Type 2/blood , Drug Interactions , Drug Therapy, Combination , Enalapril/adverse effects , Enalapril/therapeutic use , Female , Glycated Hemoglobin/metabolism , Humans , Hypertension/drug therapy , Insulin/blood , Male , Middle Aged , Prospective Studies
3.
Br Med J (Clin Res Ed)
; 290(6464): 322, 1985 Jan 26.
Article
in English
| MEDLINE
| ID: mdl-3917805